Cart
sales@molnova.com
H2L 5765834
CAS No. 420841-84-5
H2L 5765834( —— )
Catalog No. M24386 CAS No. 420841-84-5
H2L 5765834 is a lysophosphatidic acid receptors antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 126 | In Stock |
|
| 5MG | 116 | In Stock |
|
| 10MG | 187 | In Stock |
|
| 25MG | 353 | In Stock |
|
| 50MG | 514 | In Stock |
|
| 100MG | 732 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameH2L 5765834
-
NoteResearch use only, not for human use.
-
Brief DescriptionH2L 5765834 is a lysophosphatidic acid receptors antagonist.
-
DescriptionH2L 5765834 is a lysophosphatidic acid receptors antagonist.
-
In VitroH2L 5765834 displays no effect on LPA2 or LPA4 receptors.H2L 5765834 inhibits LPA-induced platelet shape change with an IC50 of 13.73±2.52 μM.
-
In VivoH2L 5765834 (20 mg/kg; i.p.) could not affect the LPA-induced decrease of alanine transaminase (ALT) in the acetaminophen (APAP) overdose-induced acute liver injury model.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetLPA Receptor
-
Recptorlysophosphatidic acid receptors
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number420841-84-5
-
Formula Weight404.33
-
Molecular FormulaC21H12N2O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:40mg/ml(98.93mM; need ultrasonic)
-
SMILES[O-][N+](c(cc1)ccc1Oc1cc(N(C(c(cc2)c3cc2C(O)=O)=O)C3=O)ccc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tetradecyl Phosphona...
Tetradecyl phosphonate is a pan-antagonist of lysophosphatidic acid 1 (LPA1) LPA2 and LPA3 receptors.
-
Radioprotectin-1
Radioprotectin-1 is a selective agonist of LPA2 with EC50 of 25 nM for murine LPA2 GPCR and exerts radioprotective and radiomitigative action.
-
UCM-05194
UCM-05194 is a selective LPA1 receptor agonist that can improve neuropathic pain and can be used in the study of progressive system diseases.
